28/05/2026
PRESS RELEASE Cercare Medical Receives FDA 510(k) Clearance for Cone-Beam CT Perfusion Enabling Real-Time Tissue Assessment Directly in the Angio Suite for Acute Stroke Patients. AARHUS, DENMARK, 28 May 2026: Cercare Medical, a leader in advanced neuroimaging software, today announced FDA 510(k) clearance (K253831) for its Cone-Beam CT (CBCT) Perfusion solution, enabling qualitative perfusion assessment […]
Read